冠状病毒主要蛋白酶的结晶结构与非共价抑制剂X77复合在一起
Haihai Jiang1, Wenwen Li2, Xuelan Zhou2
1School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
International journal of biological macromolecules
|July 9, 2024
概括
抗病毒X77有效抑制多个冠状病毒主要蛋白酶 (Mpros),包括来自SARS-CoV-2变种的蛋白酶. 结构分析揭示了X7777的存在.
科学领域:
- 结构生物学 结构生物学
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
背景情况:
- 冠状病毒具有保存的主要蛋白酶 (Mpros),对病毒复制至关重要.
- Mpros是开发针对冠状病毒的广泛抗病毒药物的关键目标.
- 最初针对SARS-CoV开发的X77抑制剂显示出对SARS-CoV-2 Mpro的潜在作用.
研究的目的:
- 阐明X77对冠状病毒Mpros.的宽谱抑制背后的分子机制.
- 了解X77与来自SARS-CoV-2,SARS-CoV和MERS-CoV的Mpros的结合相互作用.
- 以X77架构为基础的新型泛冠状病毒抗病毒药物的合理设计为指导.
主要方法:
- 进行X射线晶体学以确定与X77.7结合的Mpros的结构.
- 分子动力学模拟以评估结合稳定性.
- 具有约束力的自由能量计算来量化抑制功效.
主要成果:
- 晶体结构揭示了X77与SARS-CoV-2,SARS-CoV和MERS-CoV Mpros的详细结合方式.
- 分析确定了不同冠状病毒Mpros的X77相互作用的关键结构决定因素.
- 分子模拟证实了X77的强烈抑制,并突出了跨变体结合的相似性/差异.
结论:
- X77对包括SARS-CoV-2变种在内的多种冠状病毒Mpros具有广泛的疗效.
- 结构洞察力为设计下一代针对Mpros的抗病毒药物提供了基础.
- X77作为开发泛冠状病毒疗法的宝贵支架.
相关概念视频
X-ray Crystallography
23.9K
The size of the unit cell and the arrangement of atoms in a crystal may be determined from measurements of the diffraction of X-rays by the crystal, termed X-ray crystallography.
Diffraction
Diffraction is the change in the direction of travel experienced by an electromagnetic wave when it encounters a physical barrier whose dimensions are comparable to those of the wavelength of the light. X-rays are electromagnetic radiation with wavelengths about as long as the distance between neighboring...
Diffraction
Diffraction is the change in the direction of travel experienced by an electromagnetic wave when it encounters a physical barrier whose dimensions are comparable to those of the wavelength of the light. X-rays are electromagnetic radiation with wavelengths about as long as the distance between neighboring...
23.9K
Enzyme Inhibition
78.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.2K
Protein Complexes with Interchangeable Parts
1.8K
1.8K


